ZA786746B - Steroids and preparation - Google Patents

Steroids and preparation

Info

Publication number
ZA786746B
ZA786746B ZA00786746A ZA786746A ZA786746B ZA 786746 B ZA786746 B ZA 786746B ZA 00786746 A ZA00786746 A ZA 00786746A ZA 786746 A ZA786746 A ZA 786746A ZA 786746 B ZA786746 B ZA 786746B
Authority
ZA
South Africa
Prior art keywords
steroids
preparation
Prior art date
Application number
ZA00786746A
Other languages
English (en)
Inventor
R Christiansen
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of ZA786746B publication Critical patent/ZA786746B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0063—Nitrogen and oxygen at position 2(3)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA00786746A 1977-12-20 1978-12-01 Steroids and preparation ZA786746B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/862,417 US4160027A (en) 1977-12-20 1977-12-20 Steroid cyanoketones and intermediates

Publications (1)

Publication Number Publication Date
ZA786746B true ZA786746B (en) 1979-11-28

Family

ID=25338450

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00786746A ZA786746B (en) 1977-12-20 1978-12-01 Steroids and preparation

Country Status (27)

Country Link
US (1) US4160027A (xx)
JP (2) JPS5488253A (xx)
AR (1) AR222645A1 (xx)
AT (1) AT367070B (xx)
AU (1) AU518997B2 (xx)
BE (1) BE872886A (xx)
CA (1) CA1121340A (xx)
CH (1) CH637409A5 (xx)
DE (1) DE2855091A1 (xx)
DK (1) DK156727C (xx)
ES (1) ES476117A1 (xx)
FI (1) FI66010C (xx)
FR (1) FR2412569A1 (xx)
GB (2) GB2088878B (xx)
HK (1) HK89287A (xx)
IE (1) IE48076B1 (xx)
IL (1) IL56076A (xx)
IT (1) IT1195258B (xx)
LU (1) LU80673A1 (xx)
MX (1) MX5535E (xx)
NL (1) NL190848C (xx)
NO (1) NO151467C (xx)
NZ (1) NZ189035A (xx)
PH (2) PH14778A (xx)
PT (1) PT68926A (xx)
SE (1) SE433221B (xx)
ZA (1) ZA786746B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349474A (en) * 1981-07-27 1982-09-14 G. D. Searle & Co. 2-Cyanosteroids
ES8504486A1 (es) * 1982-11-02 1985-05-01 Sterwin Ag Procedimiento de trituracion de compuestos esteroides
DK23984A (da) * 1983-02-11 1984-08-12 Hoffmann La Roche D-homosteroider
US4459235A (en) * 1983-03-03 1984-07-10 G. D. Searle & Co. 2-Cyanosteroids
GB8328929D0 (en) * 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
GB8404980D0 (en) * 1984-02-25 1984-03-28 Sterwin Ag Steroid compound
DE3531903A1 (de) * 1985-09-05 1987-03-12 Schering Ag Oxytocin und antigestagen zur einleitung der geburt bzw. zum therapeutischen abbruch der graviditaet
US4755595A (en) * 1985-11-01 1988-07-05 Sterling Drug Inc. Enhanced production of 4,5-unsaturated steroids utilizing methanol solvation
US4833133A (en) * 1986-05-22 1989-05-23 Sterling Drug Inc. Method of regulating fertility in cattle using epostane
US4870068A (en) * 1986-05-22 1989-09-26 Sterling Drug Inc. Method of regulating fertility in swine using epostane
US5795881A (en) * 1987-06-16 1998-08-18 Schering Aktiengesellschaft Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type
US5215978A (en) * 1989-06-16 1993-06-01 The Upjohn Company Method of enhancing egg laying in turkeys using epostane
JPH0538929A (ja) * 1991-08-02 1993-02-19 Mitsubishi Heavy Ind Ltd 車両用空気調和装置
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
GB2414238B (en) * 2004-05-22 2006-12-13 Stegram Pharmaceuticals Ltd Method for the preparation of trilostane
EP2468282A3 (en) * 2005-07-12 2012-09-12 DMI Biosciences, Inc. Methods and products for treatment of diseases
SG2014008171A (en) * 2009-06-22 2014-04-28 Ampio Pharmaceuticals Inc Method for treatment of diseases
US20100323991A1 (en) * 2009-06-22 2010-12-23 Dmi Acquisition Corp. Methods and products for treatment of diseases
SG10201705044YA (en) 2012-12-19 2017-07-28 Ampio Pharmaceuticals Inc Method for treatment of diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296255A (en) * 1963-11-29 1967-01-03 Sterling Drug Inc 2-cyano steroids
US3980638A (en) * 1974-09-20 1976-09-14 The Upjohn Company Testosterone derivatives
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound

Also Published As

Publication number Publication date
AU4208978A (en) 1979-06-28
FR2412569A1 (fr) 1979-07-20
JPS62142198A (ja) 1987-06-25
DK156727C (da) 1990-03-12
PH14778A (en) 1981-12-09
JPS6220998B2 (xx) 1987-05-11
FI783901A (fi) 1979-06-21
PH16835A (en) 1984-03-15
FR2412569B1 (xx) 1982-05-28
IL56076A0 (en) 1979-01-31
NO784281L (no) 1979-06-21
GB2088878B (en) 1983-01-19
AU518997B2 (en) 1981-10-29
GB2010278A (en) 1979-06-27
AT367070B (de) 1982-05-25
DK569678A (da) 1979-06-21
HK89287A (en) 1987-12-11
US4160027A (en) 1979-07-03
GB2088878A (en) 1982-06-16
SE7813067L (sv) 1979-06-21
AR222645A1 (es) 1981-06-15
ATA888578A (de) 1981-10-15
NL190848B (nl) 1994-04-18
JPS5488253A (en) 1979-07-13
IT7831011A0 (it) 1978-12-19
JPS6361314B2 (xx) 1988-11-28
CA1121340A (en) 1982-04-06
NO151467B (no) 1985-01-02
LU80673A1 (fr) 1979-07-20
FI66010C (fi) 1984-08-10
DE2855091C2 (xx) 1988-12-22
SE433221B (sv) 1984-05-14
FI66010B (fi) 1984-04-30
CH637409A5 (fr) 1983-07-29
NZ189035A (en) 1980-08-26
NL7812309A (nl) 1979-06-22
PT68926A (en) 1979-01-01
MX5535E (es) 1983-09-27
DK156727B (da) 1989-09-25
NL190848C (nl) 1994-09-16
NO151467C (no) 1985-04-17
ES476117A1 (es) 1979-11-16
BE872886A (fr) 1979-06-20
GB2010278B (en) 1982-10-20
IE782492L (en) 1979-06-20
IE48076B1 (en) 1984-09-19
IT1195258B (it) 1988-10-12
IL56076A (en) 1983-06-15
DE2855091A1 (de) 1979-06-28

Similar Documents

Publication Publication Date Title
NZ187452A (en) N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation
JPS5479915A (en) Structure panel and its preparation
JPS5422394A (en) Substituted naphthyridinone and its preparation
GB2010278B (en) Steroids and preparation
JPS5455734A (en) 155oxygenated sterol compound and use thereof
JPS5414378A (en) Complex and its manufacture
JPS5446781A (en) Cycloaminal and its preparation
GB2007216B (en) Isochromans siothiochromans 2-benzoxepins and benzothieps
JPS53127438A (en) Composition and its preparation
JPS5477643A (en) Adhesive and its preparation
GB2001630B (en) Inosadiamine derivatives and their preparation
JPS5424896A (en) Benzodiazepineediones*preparation and use thereof
JPS5452067A (en) Arylphosphonite and thiophosphonite
JPS5441851A (en) Arylphosphonite and thiophosphonite
JPS53111095A (en) Pyroloquinoxalines and pyrolobenzodiazepinons
IL54252A0 (en) Novel -aryl-acetamide derivatives and their preparation
JPS53111041A (en) Composition and its preparation
JPS5452078A (en) 11alkylimidazole and its manufacture
JPS53135957A (en) Composition and its preparation
GB2004542B (en) Beta-substituted-diketones and preparation thereof
JPS5416486A (en) Novel pyridazinylhydrazones and its preparation
JPS53132546A (en) Composition and its preparation
JPS5481237A (en) Alphaaalkyldihydrocinnamaldehydes and manufacture
IL56031A0 (en) Novel dichlorovinylcyclobutanones and their preparation
IL54013A0 (en) Everninomicin derivatives and their preparation